(Q35005169)

5 August 2017

Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication (English)

1 reference

5 August 2017

0 references

1 reference

9

Toshifumi Hibi

1 reference

5 August 2017

Toshihiro Nishizawa

1

1 reference

5 August 2017

Hidekazu Suzuki

2

1 reference

5 August 2017

Hitoshi Tsugawa

3

1 reference

5 August 2017

Hiroe Muraoka

4

1 reference

5 August 2017

Juntaro Matsuzaki

5

1 reference

5 August 2017

Kenro Hirata

6

1 reference

5 August 2017

Fumiaki Ikeda

7

1 reference

5 August 2017

Masahiko Takahashi

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

12 April 2011

1 reference

Antimicrobial Agents and Chemotherapy

5 August 2017

1 reference

5 August 2017

55

1 reference

5 August 2017

6

1 reference

5 August 2017

3012-3014

1 reference

Helicobacter pylori eradication therapy

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101459

Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21486961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00188-11

1 reference

5 August 2017

1 reference

5 August 2017

1 reference